Literature DB >> 21988950

Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine.

Michael Ehle1, Chandni Patel, Robert P Giugliano.   

Abstract

Digoxin is the oldest cardiac medication used in contemporary medicine. With a complex pharmacokinetic profile and narrow therapeutic index, its use in managing patients with atrial arrhythmias or heart failure can present a challenge to today's clinicians. Digoxin dosing based on patient-specific factors such as age, lean body weight, and renal function will allow practitioners to minimize drug toxicity while maintaining clinical efficacy. The ability to recognize digoxin overdose, which can manifest in both the acute and chronic settings, helps guide the appropriate dosing of digoxin immune globulins to reverse toxicity. Understanding this unique medication is essential for clinicians to ensure digoxin is used safely and effectively in practice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21988950     DOI: 10.1097/HPC.0b013e318221e7dd

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  29 in total

1.  Digoxin toxicity: Case for retiring its use in elderly patients?

Authors:  Nora MacLeod-Glover; Matthew Mink; Mark Yarema; Ryan Chuang
Journal:  Can Fam Physician       Date:  2016-03       Impact factor: 3.275

2.  Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan.

Authors:  Chia-Lin Chou; Chia-Chen Hsu; Chia-Yu Chou; Tzeng-Ji Chen; Li-Fang Chou; Yueh-Ching Chou
Journal:  Int J Clin Pharm       Date:  2015-09-23

3.  Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects.

Authors:  Lan-Xiang Wu; Chun-Jie Wen; Ying Li; Xue Zhang; Ying-Ying Shao; Zhu Yang; Hong-Hao Zhou
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

4.  High-throughput screening of small molecules identifies hepcidin antagonists.

Authors:  Eileen Fung; Priscilla Sugianto; Jason Hsu; Robert Damoiseaux; Tomas Ganz; Elizabeta Nemeth
Journal:  Mol Pharmacol       Date:  2013-01-04       Impact factor: 4.436

5.  Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by different growth factors.

Authors:  Annalisa Trenti; Elisabetta Zulato; Lorenza Pasqualini; Stefano Indraccolo; Chiara Bolego; Lucia Trevisi
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

6.  Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.

Authors:  Dirk Theile; Walter Emil Haefeli; Johanna Weiss
Journal:  Endocrine       Date:  2014-12-27       Impact factor: 3.633

Review 7.  Protein engineering: a new frontier for biological therapeutics.

Authors:  Peter H Tobin; David H Richards; Randolph A Callender; Corey J Wilson
Journal:  Curr Drug Metab       Date:  2014       Impact factor: 3.731

8.  Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma.

Authors:  Lei Huang; Sarah Garrett Injac; Kemi Cui; Frank Braun; Qi Lin; Yuchen Du; Huiyuan Zhang; Mari Kogiso; Holly Lindsay; Sibo Zhao; Patricia Baxter; Adesina Adekunle; Tsz-Kwong Man; Hong Zhao; Xiao-Nan Li; Ching C Lau; Stephen T C Wong
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

9.  Accurate mass-time tag library for LC/MS-based metabolite profiling of medicinal plants.

Authors:  Daniel J Cuthbertson; Sean R Johnson; Jasenka Piljac-Žegarac; Julia Kappel; Sarah Schäfer; Matthias Wüst; Raymond E B Ketchum; Rodney B Croteau; Joaquim V Marques; Laurence B Davin; Norman G Lewis; Megan Rolf; Toni M Kutchan; D Doel Soejarto; B Markus Lange
Journal:  Phytochemistry       Date:  2013-04-16       Impact factor: 4.072

Review 10.  A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population.

Authors:  Mariam H Abdel Jalil; Noura Abdullah; Mervat M Alsous; Mohammad Saleh; Khawla Abu-Hammour
Journal:  Br J Clin Pharmacol       Date:  2020-04-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.